Muscle-invasive bladder cancer is a potentially lethal disease often impacting elder and comorbid patients. Neoadjuvant chemotherapy followed by radical cystectomy is associated with morbidity and is an option that many patients refuse. Maximal transurethral resection of bladder tumor (TURBT) as part of a bladder preservation strategy can achieve surgical cure and may improve long-term recurrence-free survival. We encourage bladder preservation after maximal TURBT for appropriate patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.euf.2022.10.011 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!